Replies to post #160697 on Cytodyn Inc (CYDY)

[DonDonDonDon]

They gambled heavily on combining both groups to get the P value they wanted and lost.

The CD10 and CD12 trials weren't meant to get approval. They literally tried every group: mild, moderate, severe, critical. They were just looking where they might have efficacy like throwing spaghetti against the wall and seeing what sticks. They ended up with 24% efficacy on 62 critical patients. Such a disappointment.

[Latane]

Just bought 7000 more shares...


Signed - Retail Investor

[misiu143]

People with minimal understanding of Leronlimab mode of action , and who know how to evaluate the results , people reading papers , of Dr Patterson , Dr Harish S , Dr Agasti , Dr Yang and others , will never make an in-responsible statements about Leronlimab..

It was very good when during this meeting in Philippine doctors commented about the type of studies Remdesivire and Lenzilumab did..

" it was adaptive design , they saw the results during their study , it was not a real double blind "

How true , medical doctors know how to evaluate accuracy of his type od study compare to normal double blind placebo control .
Dr Fauci and US FDA is not fooling anyone..

Go Leronlimab , save the lives..

And as our friend like to say..

.." Sleep well shorts "..

All IMO..